The US Food and Drug Administration approved updated Covid-19 vaccines but for a more limited group: adults age 65 and older and younger people who are at higher risk from Covid-19.

“FDA has now issued marketing authorization for those at higher risk: Moderna (6+ months), Pfizer (5+), and Novavax (12+). These vaccines are available for all patients who choose them after consulting with their doctors,” US Health and Human Services Secretary Robert F. Kennedy Jr. said in a post on X.

This is a breaking news story and will be updated.

See Full Page